Gentamicin Concentration Gradients in Scala Tympani Perilymph following Systemic Applications
It has been shown in prior studies that round window membrane (RWM) application of gentamicin produced a robust basal-apical concentration gradient in the perilymph of scala tympani (ST) with peak concentrations in the basal turn of ST. These gradients potentially contribute to the clinical efficacy...
Gespeichert in:
Veröffentlicht in: | Audiology & neurotology 2013-01, Vol.18 (6), p.383-391 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 391 |
---|---|
container_issue | 6 |
container_start_page | 383 |
container_title | Audiology & neurotology |
container_volume | 18 |
creator | Hahn, Hartmut Salt, Alec N. Schumacher, Ulrike Plontke, Stefan K. |
description | It has been shown in prior studies that round window membrane (RWM) application of gentamicin produced a robust basal-apical concentration gradient in the perilymph of scala tympani (ST) with peak concentrations in the basal turn of ST. These gradients potentially contribute to the clinical efficacy and safety of intratympanic gentamicin applications for the treatment of Ménière's disease. The present study aimed to establish the distribution of gentamicin along ST perilymph after systemic applications. Gentamicin sulfate was applied intravenously in the amounts of 100, 300 and 600 mg/kg body weight (BW) over a period of 3 h or as a 300 mg/kg BW subcutaneous bolus injection. At 3 and 5 h after the start of the application perilymph of ST was aspirated from the cochlea apex of the right and left cochlea, respectively, and 10 sequential 1-µl perilymph samples from the apex of each cochlea were quantitatively analyzed using a fluorescence polarization immunoassay. In contrast to local RWM delivery, systemic application of gentamicin resulted in the highest perilymph levels in the apex of the cochlea with decreasing concentrations towards the basal regions of ST. The absolute gentamicin concentrations increased with the amount of drug applied and time before sampling. While it is likely that the basal-apical gradient measured after local drug applications to the round window niche is the result of the direct uptake of drugs into the perilymph of the ST, distribution by diffusion and a very low perilymph flow towards the cochlear apex, computer simulations suggested that the apical-basal gradient observed with these systemic applications can be explained by higher entry rates of gentamicin in the apex compared to the basal turns of the cochlea. It is also possible that gentamicin enters perilymph indirectly from the blood via the endolymph. In this case the faster kinetics in apical turns could be due to the smaller cross-sectional area of ST relative to endolymph in the apical turns. |
doi_str_mv | 10.1159/000355283 |
format | Article |
fullrecord | <record><control><sourceid>proquest_karge</sourceid><recordid>TN_cdi_karger_primary_355283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1492611282</sourcerecordid><originalsourceid>FETCH-LOGICAL-c523t-9c9d457fca23d362ce6239eda632a5a348d0cdd59db4a6eba2c5b2b1bb4c631d3</originalsourceid><addsrcrecordid>eNpdkd9LHDEQx4O0qFUffC-y4Ev7sJqfe5sXQY72WhAU1EcJs0nujGaTNdlruf--0bsetU8zw3zmy8x8ETom-IwQIc8xxkwI2rIdtE84JbWcYPzhLcc1wwzvoU85PxVMCMF30R7lRNKmaffRw8yGEXqnXaimMehSJRhdDNUsgXGlzFVp3WrwUN2t-gGCq25scr7kj9U8eh9_u7Cobld5tEWnuhwG7_SbRj5EH-fgsz3axAN0__3b3fRHfXU9-zm9vKq1oGyspZaGi8lcA2WGNVTbhjJpDTSMggDGW4O1MUKajkNjO6BadLQjXcd1w4hhB-hirTssu96a9RVeDcn1kFYqglPvO8E9qkX8pZgkLWeyCHzZCKT4srR5VL3L2noPwcZlVoSXfxFCW1rQ0__Qp7hMoZxXqAlpCG_pK_V1TekUc052vl2GYPVqmtqaVtiTf7ffkn9dKsDnNfAMaWHTFtjM_wGlApzn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1471614822</pqid></control><display><type>article</type><title>Gentamicin Concentration Gradients in Scala Tympani Perilymph following Systemic Applications</title><source>MEDLINE</source><source>Karger Journals</source><source>Alma/SFX Local Collection</source><creator>Hahn, Hartmut ; Salt, Alec N. ; Schumacher, Ulrike ; Plontke, Stefan K.</creator><creatorcontrib>Hahn, Hartmut ; Salt, Alec N. ; Schumacher, Ulrike ; Plontke, Stefan K.</creatorcontrib><description>It has been shown in prior studies that round window membrane (RWM) application of gentamicin produced a robust basal-apical concentration gradient in the perilymph of scala tympani (ST) with peak concentrations in the basal turn of ST. These gradients potentially contribute to the clinical efficacy and safety of intratympanic gentamicin applications for the treatment of Ménière's disease. The present study aimed to establish the distribution of gentamicin along ST perilymph after systemic applications. Gentamicin sulfate was applied intravenously in the amounts of 100, 300 and 600 mg/kg body weight (BW) over a period of 3 h or as a 300 mg/kg BW subcutaneous bolus injection. At 3 and 5 h after the start of the application perilymph of ST was aspirated from the cochlea apex of the right and left cochlea, respectively, and 10 sequential 1-µl perilymph samples from the apex of each cochlea were quantitatively analyzed using a fluorescence polarization immunoassay. In contrast to local RWM delivery, systemic application of gentamicin resulted in the highest perilymph levels in the apex of the cochlea with decreasing concentrations towards the basal regions of ST. The absolute gentamicin concentrations increased with the amount of drug applied and time before sampling. While it is likely that the basal-apical gradient measured after local drug applications to the round window niche is the result of the direct uptake of drugs into the perilymph of the ST, distribution by diffusion and a very low perilymph flow towards the cochlear apex, computer simulations suggested that the apical-basal gradient observed with these systemic applications can be explained by higher entry rates of gentamicin in the apex compared to the basal turns of the cochlea. It is also possible that gentamicin enters perilymph indirectly from the blood via the endolymph. In this case the faster kinetics in apical turns could be due to the smaller cross-sectional area of ST relative to endolymph in the apical turns.</description><identifier>ISSN: 1420-3030</identifier><identifier>EISSN: 1421-9700</identifier><identifier>DOI: 10.1159/000355283</identifier><identifier>PMID: 24192668</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Animals ; Anti-Bacterial Agents - blood ; Anti-Bacterial Agents - pharmacokinetics ; Anti-Bacterial Agents - toxicity ; Blood ; Cochlea - metabolism ; Computer Simulation ; Dose-Response Relationship, Drug ; Drug delivery systems ; Endolymph - metabolism ; Female ; Gentamicins - blood ; Gentamicins - pharmacokinetics ; Gentamicins - toxicity ; Guinea Pigs ; Hearing loss ; Injections, Intravenous ; Injections, Subcutaneous ; Male ; Models, Biological ; Original Paper ; Otolaryngology ; Perilymph - metabolism ; Pharmacology ; Scala Tympani - metabolism ; Studies</subject><ispartof>Audiology & neurotology, 2013-01, Vol.18 (6), p.383-391</ispartof><rights>2013 S. Karger AG, Basel</rights><rights>2013 S. Karger AG, Basel.</rights><rights>Copyright (c) 2013 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c523t-9c9d457fca23d362ce6239eda632a5a348d0cdd59db4a6eba2c5b2b1bb4c631d3</citedby><cites>FETCH-LOGICAL-c523t-9c9d457fca23d362ce6239eda632a5a348d0cdd59db4a6eba2c5b2b1bb4c631d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,2423,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24192668$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hahn, Hartmut</creatorcontrib><creatorcontrib>Salt, Alec N.</creatorcontrib><creatorcontrib>Schumacher, Ulrike</creatorcontrib><creatorcontrib>Plontke, Stefan K.</creatorcontrib><title>Gentamicin Concentration Gradients in Scala Tympani Perilymph following Systemic Applications</title><title>Audiology & neurotology</title><addtitle>Audiol Neurotol</addtitle><description>It has been shown in prior studies that round window membrane (RWM) application of gentamicin produced a robust basal-apical concentration gradient in the perilymph of scala tympani (ST) with peak concentrations in the basal turn of ST. These gradients potentially contribute to the clinical efficacy and safety of intratympanic gentamicin applications for the treatment of Ménière's disease. The present study aimed to establish the distribution of gentamicin along ST perilymph after systemic applications. Gentamicin sulfate was applied intravenously in the amounts of 100, 300 and 600 mg/kg body weight (BW) over a period of 3 h or as a 300 mg/kg BW subcutaneous bolus injection. At 3 and 5 h after the start of the application perilymph of ST was aspirated from the cochlea apex of the right and left cochlea, respectively, and 10 sequential 1-µl perilymph samples from the apex of each cochlea were quantitatively analyzed using a fluorescence polarization immunoassay. In contrast to local RWM delivery, systemic application of gentamicin resulted in the highest perilymph levels in the apex of the cochlea with decreasing concentrations towards the basal regions of ST. The absolute gentamicin concentrations increased with the amount of drug applied and time before sampling. While it is likely that the basal-apical gradient measured after local drug applications to the round window niche is the result of the direct uptake of drugs into the perilymph of the ST, distribution by diffusion and a very low perilymph flow towards the cochlear apex, computer simulations suggested that the apical-basal gradient observed with these systemic applications can be explained by higher entry rates of gentamicin in the apex compared to the basal turns of the cochlea. It is also possible that gentamicin enters perilymph indirectly from the blood via the endolymph. In this case the faster kinetics in apical turns could be due to the smaller cross-sectional area of ST relative to endolymph in the apical turns.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - blood</subject><subject>Anti-Bacterial Agents - pharmacokinetics</subject><subject>Anti-Bacterial Agents - toxicity</subject><subject>Blood</subject><subject>Cochlea - metabolism</subject><subject>Computer Simulation</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug delivery systems</subject><subject>Endolymph - metabolism</subject><subject>Female</subject><subject>Gentamicins - blood</subject><subject>Gentamicins - pharmacokinetics</subject><subject>Gentamicins - toxicity</subject><subject>Guinea Pigs</subject><subject>Hearing loss</subject><subject>Injections, Intravenous</subject><subject>Injections, Subcutaneous</subject><subject>Male</subject><subject>Models, Biological</subject><subject>Original Paper</subject><subject>Otolaryngology</subject><subject>Perilymph - metabolism</subject><subject>Pharmacology</subject><subject>Scala Tympani - metabolism</subject><subject>Studies</subject><issn>1420-3030</issn><issn>1421-9700</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpdkd9LHDEQx4O0qFUffC-y4Ev7sJqfe5sXQY72WhAU1EcJs0nujGaTNdlruf--0bsetU8zw3zmy8x8ETom-IwQIc8xxkwI2rIdtE84JbWcYPzhLcc1wwzvoU85PxVMCMF30R7lRNKmaffRw8yGEXqnXaimMehSJRhdDNUsgXGlzFVp3WrwUN2t-gGCq25scr7kj9U8eh9_u7Cobld5tEWnuhwG7_SbRj5EH-fgsz3axAN0__3b3fRHfXU9-zm9vKq1oGyspZaGi8lcA2WGNVTbhjJpDTSMggDGW4O1MUKajkNjO6BadLQjXcd1w4hhB-hirTssu96a9RVeDcn1kFYqglPvO8E9qkX8pZgkLWeyCHzZCKT4srR5VL3L2noPwcZlVoSXfxFCW1rQ0__Qp7hMoZxXqAlpCG_pK_V1TekUc052vl2GYPVqmtqaVtiTf7ffkn9dKsDnNfAMaWHTFtjM_wGlApzn</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Hahn, Hartmut</creator><creator>Salt, Alec N.</creator><creator>Schumacher, Ulrike</creator><creator>Plontke, Stefan K.</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7TK</scope><scope>5PM</scope></search><sort><creationdate>20130101</creationdate><title>Gentamicin Concentration Gradients in Scala Tympani Perilymph following Systemic Applications</title><author>Hahn, Hartmut ; Salt, Alec N. ; Schumacher, Ulrike ; Plontke, Stefan K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c523t-9c9d457fca23d362ce6239eda632a5a348d0cdd59db4a6eba2c5b2b1bb4c631d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - blood</topic><topic>Anti-Bacterial Agents - pharmacokinetics</topic><topic>Anti-Bacterial Agents - toxicity</topic><topic>Blood</topic><topic>Cochlea - metabolism</topic><topic>Computer Simulation</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug delivery systems</topic><topic>Endolymph - metabolism</topic><topic>Female</topic><topic>Gentamicins - blood</topic><topic>Gentamicins - pharmacokinetics</topic><topic>Gentamicins - toxicity</topic><topic>Guinea Pigs</topic><topic>Hearing loss</topic><topic>Injections, Intravenous</topic><topic>Injections, Subcutaneous</topic><topic>Male</topic><topic>Models, Biological</topic><topic>Original Paper</topic><topic>Otolaryngology</topic><topic>Perilymph - metabolism</topic><topic>Pharmacology</topic><topic>Scala Tympani - metabolism</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hahn, Hartmut</creatorcontrib><creatorcontrib>Salt, Alec N.</creatorcontrib><creatorcontrib>Schumacher, Ulrike</creatorcontrib><creatorcontrib>Plontke, Stefan K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Neurosciences Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Audiology & neurotology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hahn, Hartmut</au><au>Salt, Alec N.</au><au>Schumacher, Ulrike</au><au>Plontke, Stefan K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gentamicin Concentration Gradients in Scala Tympani Perilymph following Systemic Applications</atitle><jtitle>Audiology & neurotology</jtitle><addtitle>Audiol Neurotol</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>18</volume><issue>6</issue><spage>383</spage><epage>391</epage><pages>383-391</pages><issn>1420-3030</issn><eissn>1421-9700</eissn><abstract>It has been shown in prior studies that round window membrane (RWM) application of gentamicin produced a robust basal-apical concentration gradient in the perilymph of scala tympani (ST) with peak concentrations in the basal turn of ST. These gradients potentially contribute to the clinical efficacy and safety of intratympanic gentamicin applications for the treatment of Ménière's disease. The present study aimed to establish the distribution of gentamicin along ST perilymph after systemic applications. Gentamicin sulfate was applied intravenously in the amounts of 100, 300 and 600 mg/kg body weight (BW) over a period of 3 h or as a 300 mg/kg BW subcutaneous bolus injection. At 3 and 5 h after the start of the application perilymph of ST was aspirated from the cochlea apex of the right and left cochlea, respectively, and 10 sequential 1-µl perilymph samples from the apex of each cochlea were quantitatively analyzed using a fluorescence polarization immunoassay. In contrast to local RWM delivery, systemic application of gentamicin resulted in the highest perilymph levels in the apex of the cochlea with decreasing concentrations towards the basal regions of ST. The absolute gentamicin concentrations increased with the amount of drug applied and time before sampling. While it is likely that the basal-apical gradient measured after local drug applications to the round window niche is the result of the direct uptake of drugs into the perilymph of the ST, distribution by diffusion and a very low perilymph flow towards the cochlear apex, computer simulations suggested that the apical-basal gradient observed with these systemic applications can be explained by higher entry rates of gentamicin in the apex compared to the basal turns of the cochlea. It is also possible that gentamicin enters perilymph indirectly from the blood via the endolymph. In this case the faster kinetics in apical turns could be due to the smaller cross-sectional area of ST relative to endolymph in the apical turns.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>24192668</pmid><doi>10.1159/000355283</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1420-3030 |
ispartof | Audiology & neurotology, 2013-01, Vol.18 (6), p.383-391 |
issn | 1420-3030 1421-9700 |
language | eng |
recordid | cdi_karger_primary_355283 |
source | MEDLINE; Karger Journals; Alma/SFX Local Collection |
subjects | Animals Anti-Bacterial Agents - blood Anti-Bacterial Agents - pharmacokinetics Anti-Bacterial Agents - toxicity Blood Cochlea - metabolism Computer Simulation Dose-Response Relationship, Drug Drug delivery systems Endolymph - metabolism Female Gentamicins - blood Gentamicins - pharmacokinetics Gentamicins - toxicity Guinea Pigs Hearing loss Injections, Intravenous Injections, Subcutaneous Male Models, Biological Original Paper Otolaryngology Perilymph - metabolism Pharmacology Scala Tympani - metabolism Studies |
title | Gentamicin Concentration Gradients in Scala Tympani Perilymph following Systemic Applications |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T07%3A04%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gentamicin%20Concentration%20Gradients%20in%20Scala%20Tympani%20Perilymph%20following%20Systemic%20Applications&rft.jtitle=Audiology%20&%20neurotology&rft.au=Hahn,%20Hartmut&rft.date=2013-01-01&rft.volume=18&rft.issue=6&rft.spage=383&rft.epage=391&rft.pages=383-391&rft.issn=1420-3030&rft.eissn=1421-9700&rft_id=info:doi/10.1159/000355283&rft_dat=%3Cproquest_karge%3E1492611282%3C/proquest_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1471614822&rft_id=info:pmid/24192668&rfr_iscdi=true |